Blood cell counts during treatment of neuroendocrine tumors with [111-In-DTPA]octreotide

被引：0
|
作者：
van Hagen, PM
Valkema, R
Tse, WK
Kwekkeboom, DJ
de Herder, WW
Hooykaas, H
Krenning, EP
机构：
[1] Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Nucl Med, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus Univ, Dept Internal Med 3, NL-3000 DR Rotterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1999年 / 26卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
PS620
引用
收藏
页码：1207 / 1207
页数：1
相关论文
共 50 条
  • [1] Treatment of patients with neuroendocrine tumors with [111In-DTPA-D-Phe]-octreotide -: The Uppsala experience
    Janson, ET
    Garske, U
    Westlin, JE
    Welin, S
    Örlefors, H
    Granberg, D
    Skogseid, B
    Eriksson, B
    Öberg, K
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (02) : 294 - 295
  • [2] In-111-DTPA-DGlu1-minigastrin in comparison to In-111-DTPA-DPhe1-octreotide in 87 patients with neuroendocrine tumors
    Gotthardt, M
    Béhé, MP
    Rinke, A
    Herbst, B
    Pfestroff, A
    Goecke, J
    Heinis, J
    Arnold, R
    Behr, TM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S214 - S215
  • [3] Use of In-111-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results
    Oliaro, A
    Filosso, PL
    Bello, M
    Casadio, C
    Angusti, T
    Masaneo, I
    Maggi, G
    Bisi, G
    JOURNAL OF CARDIOVASCULAR SURGERY, 1997, 38 (03): : 313 - 315
  • [4] Treatment with high dose [111In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors -: Evaluation of therapeutic and toxic effects
    Janson, ET
    Eriksson, B
    Öberg, K
    Skogseid, B
    Öhrvall, U
    Nilsson, S
    Westlin, JE
    ACTA ONCOLOGICA, 1999, 38 (03) : 373 - 377
  • [5] Study of the course of neuroendocrine tumors with 111In-octreotide
    Ramos, J
    Maraña, G
    Tabuenca, MJ
    Castejón, I
    Ayllón, LJ
    Berrocal, JO
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S356 - S356
  • [6] Treatment with high dose [111In-DTPA-D-PHE1]-octreotide in patients with neuroendocrine tumors - evaluation of therapeutic and toxic effects
    Janson, Eva Tiensuu
    Eriksson, Barbro
    Oberg, Kjell
    Skogseid, Britt
    Ohrvall, Ulf
    Nilsson, Sten
    Westlin, Jan-Erik
    Acta Oncologica, 38 (03): : 373 - 377
  • [7] Therapeutic efficacy and toxicity of In-111-DTPA-D-Phe-octreotide in patients with advanced neuroendocrine tumors.
    Schipper, ML
    Gotthardt, M
    Behe, M
    Arnold, R
    Behr, TM
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 137P - 137P
  • [8] Comparison of 4 and 24 hour SPECT 111In-DTPA-octreotide scintigraphy in the detection of neuroendocrine tumors.
    Esteves, F
    Yaban, B
    Halkar, RK
    Taylor, A
    Alazraki, NP
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 28P - 28P
  • [9] Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors
    Janson, ET
    Westlin, JE
    Öhrvall, U
    Öberg, K
    Lukinius, A
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (09) : 1514 - 1518
  • [10] Use of 111-In-DTPA-octreotide scintigraphy in diagnosis of neuroendocrine carcinoma of the lung
    Filosso, PL
    Bello, M
    Bisi, G
    Canavese, G
    Casadio, C
    Oliaro, A
    Moretto, A
    Leo, F
    1ST MEDITERRANEAN CONGRESS ON INTERVENTIONAL DIAGNOSIS FOR THORAX DISEASES, 1996, : 75 - 79
12345